Trial intelligence / Profile preview

Fenofibrate and fenofibrate + pioglitazone in obese patients with type 2 diabetes mellitus

PACTR201407000856135Completed

Sponsor
Ain Shams University
Start
Aug 2014
Modality
Small Molecules
Countries
1
01

Overview

Trial of fenofibrate and pioglitazone in type 2 diabetes mellitus (T2DM) and obesity (2 arms), sponsored by Ain Shams University. Primary endpoint: Serum sirtuin 1 level. Started Aug 2014; status: completed.

02

Drugs

fenofibratepioglitazone
03

Conditions

type 2 diabetes mellitus (T2DM)obesity

Beyond the preview

Go deeper on PACTR201407000856135.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR201407000856135.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call